Contribution of pannexin 1 and connexin 43 hemichannels to extracellular calcium-dependent transport dynamics in human blood-brain barrier endothelial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 353, Issue 1, 2015, Pages 192-200

  Kaneko, Yosuke ^a   Tachikawa, Masanori ^a   Akaogi, Ryo ^a   Fujimoto, Kazuhisa ^b   Ishibashi, Megumi ^b   Uchida, Yasuo ^a   Couraud, Pierre Olivier ^c   Ohtsuki, Sumio ^d   Hosoya, Ken Ichi ^e   Terasaki, Tetsuya ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KYUSHU SANGYO UNIVERSITY   (Japan)

^c INSERM   (France)

^d KUMAMOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; AMLODIPINE; ANION; BRILLIANT BLUE G; CALCIUM ION; CATION; CILNIDIPINE; CILOSTAZOL; CONNEXIN 43; DEXAMETHASONE; DILTIAZEM; ESTRONE; FLUFENAMIC ACID; FLUINDOSTATIN; FLUORESCENT DYE; HYDROCORTISONE; MEMBRANE PROTEIN; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NORPHENAZONE; PANNEXIN 1; PRAVASTATIN; PROGESTERONE; SMALL INTERFERING RNA; TACROLIMUS; UNCLASSIFIED DRUG; VERAPAMIL; CALCIUM; GAP JUNCTION PROTEIN; GJA1 PROTEIN, HUMAN; NERVE PROTEIN; PANX1 PROTEIN, HUMAN;

ARTICLE; BLOOD BRAIN BARRIER; CELL TRANSPORT; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM CELL; EXTRACELLULAR CALCIUM; HEMICHANNEL; HUMAN; HUMAN CELL; ION TRANSPORT; MEMBRANE CHANNEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TRANSPORT KINETICS; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL MEMBRANE; CHANNEL GATING; CYTOLOGY; DRUG EFFECTS; EXTRACELLULAR SPACE; METABOLISM; MICROVASCULATURE; TRANSPORT AT THE CELLULAR LEVEL;

ANIONS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CALCIUM; CATIONS; CELL LINE; CELL MEMBRANE; CONNEXIN 43; CONNEXINS; ENDOTHELIAL CELLS; EXTRACELLULAR SPACE; FLUORESCENT DYES; HUMANS; ION CHANNEL GATING; MICROVESSELS; NERVE TISSUE PROTEINS;

EID: 84928931455     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.220210     Document Type: Article

References (37)

1. Bai D, del Corsso C, Srinivas M, and Spray DC (2006) Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB). J Pharmacol Exp Ther 319:1452-1458.
2. Bargiotas P, Monyer H, and Schwaninger M (2009) Hemichannels in cerebral ischemia. Curr Mol Med 9:186-194.
3. Bargiotas P, Krenz A, Monyer H, and Schwaninger M (2012) Functional outcome of pannexin-deficient mice after cerebral ischemia. Channels (Austin) 6:453-456.
4. 2+) signalling in the human blood-brain barrier endothelial cell line hCMEC/D3. Purinergic Signal 8:71-80.
5. Bosco D, Haefliger JA, and Meda P (2011) Connexins: key mediators of endocrine function. Physiol Rev 91:1393-1445.
6. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, and Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698.
7. De Bock M, Culot M, Wang N, Bol M, Decrock E, De Vuyst E, da Costa A, Dauwe I, Vinken M, Simon AM, et al. (2011) Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability. J Cereb Blood Flow Metab 31:1942-1957.
8. De Bock M, Culot M, Wang N, da Costa A, Decrock E, Bol M, Bultynck G, Cecchelli R, and Leybaert L (2012) Low extracellular Ca2+ conditions induce an increase in brain endothelial permeability that involves intercellular Ca2+ waves. Brain Res 1487:78-87.
9. De Bock M, Vandenbroucke RE, Decrock E, Culot M, Cecchelli R, and Leybaert L (2014) A new angle on blood-CNS interfaces: a role for connexins? FEBS Lett 588:1259-1270.
10. Evans WH, De Vuyst E, and Leybaert L (2006) The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem J 397:1-14.
11. Fang W, Lv P, Geng X, Shang E, Yang Q, Sha L, and Li Y (2013) Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation. Neurochem Int 62:23-30.
12. Gaete PS, Lillo MA, and Figueroa XF (2014) Functional role of connexins and pannexins in the interaction between vascular and nervous system. J Cell Physiol 229:1336-1345.
13. Hoshi Y, Uchida Y, Tachikawa M, Inoue T, Ohtsuki S, and Terasaki T (2013) Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset. J Pharm Sci 102:3343-3355.
14. Iglesias R, Locovei S, Roque A, Alberto AP, Dahl G, Spray DC, and Scemes E (2008) P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol 295:C752-C760.
15. Ishrat T, Sayeed I, Atif F, and Stein DG (2009) Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res 1257:94-101.
16. Ishrat T, Sayeed I, Atif F, Hua F, and Stein DG (2010) Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol 226:183-190.
17. Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, and Terasaki T (2008) Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res 25:1469-1483.
18. Koval M, Molina SA, and Burt JM (2014) Mix and match: investigating heteromeric and heterotypic gap junction channels in model systems and native tissues. FEBS Lett 588:1193-1204.
19. Li MW, Mruk DD, and Cheng CY (2012) Gap junctions and blood-tissue barriers. Adv Exp Med Biol 763:260-280.
20. MacVicar BA and Thompson RJ (2010) Non-junction functions of pannexin-1 channels. Trends Neurosci 33:93-102.
21. Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, Decleves X, Scherrmann JM, Couraud PO, Kubo Y, et al. (2013) Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human bloodbrain barrier model. Mol Pharm 10:289-296.
22. Poornima V, Madhupriya M, Kootar S, Sujatha G, Kumar A, and Bera AK (2012) P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization. J Mol Neurosci 46:585-594.
23. Qiu F and Dahl G (2009) A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am J Physiol Cell Physiol 296:C250-C255.
24. Retamal MA, Cortés CJ, Reuss L, Bennett MV, and Sáez JC (2006) S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc Natl Acad Sci USA 103:4475-4480.
25. Shestopalov VI and Panchin Y (2008) Pannexins and gap junction protein diversity. Cell Mol Life Sci 65:376-394.
26. 2+] in hypoxia and ischemia in rat brain in vivo. J Gen Physiol 95:837-866.
27. Simpson I, Rose B, and Loewenstein WR (1977) Size limit of molecules permeating the junctional membrane channels. Science 195:294-296.
28. Stout CE, Costantin JL, Naus CC, and Charles AC (2002) Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 277:10482-10488.
29. Tachikawa M, Uchida Y, Ohtsuki S, and Terasaki T (2014) Recent progress in the blood-brain barrier and the blood-CSF barrier transport research: Pharmaceutical relevance of drug delivery to the brain, in Drug Delivery to the Brain-Physiological Concepts, Methodologies and Approaches (Hammarlund-Udenaes M, de Lange E, and Thorne R, eds) pp 23-62, Springer, New York.
30. Tai LM, Reddy PS, Lopez-Ramirez MA, Davies HA, Male DK, Loughlin AJ, and Romero IA (2009) Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123. Brain Res 1292:14-24.
31. Takahara A, Konda T, Enomoto A, and Kondo N (2004) Neuroprotective effects of a dual L/N-type Ca (2+) channel blocker cilnidipine in the rat focal brain ischemia model. Biol Pharm Bull 27:1388-1391.
32. Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, Li H, Zhou Y, Mori R, Yasuoka S, et al. (2011) Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PLoS ONE 6:e21108.
33. 2+ concentration and Ca2+ extrusion measured simultaneously in single mouse pancreatic acinar cells. J Biol Chem 267:3569-3572.
34. Thompson RJ, Zhou N, and MacVicar BA (2006) Ischemia opens neuronal gap junction hemichannels. Science 312:924-927.
35. Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J, and Terasaki T (2011) Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117:333-345.
36. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, et al. (2005) Blood-brain barrierspecific properties of a human adult brain endothelial cell line. FASEB J 19:1872-1874.
37. Yamaoka K, Tanaka H, Okumura K, Yasuhara M, and Hori R (1986) An analysis program MULTI (ELS) based on extended nonlinear least squares method for microcomputers. J Pharmacobiodyn 9:161-173.